India To Set Up CRISPR Innovation Centre In Bengaluru
Technology

India To Set Up CRISPR Innovation Centre In Bengaluru

A new Letter of Intent has been signed to establish a Centre of Excellence for CRISPR Innovation and Translation, aimed at harnessing advanced CRISPR technologies to convert laboratory research into real-world clinical applications. The proposed centre will act as a dedicated hub to accelerate the translation of scientific discoveries into affordable and scalable healthcare solutions.

The Jawaharlal Nehru Centre for Advanced Scientific Research, Bengaluru—an autonomous institute under the Department of Science and Technology—and Delhi-based CrisprBits Private Limited have jointly announced the initiative, marking one of India’s early public–private partnerships in CRISPR-based biotechnology. CrisprBits specialises in gene-editing platforms focused on developing cost-effective diagnostic and therapeutic solutions.

The Centre of Excellence is envisioned as a bridge between fundamental research and clinical impact, combining JNCASR’s strengths in biomedical sciences with CrisprBits’ expertise in applied gene-editing and translational technologies. By addressing the long-standing gap between laboratory innovation and bedside application, the centre aims to demonstrate how Indian scientific research can be effectively transformed into societal and clinical benefits. It is also expected to serve as a replicable national model for strengthening collaboration between academia and industry within India’s biotechnology ecosystem.

Commenting on the development, JNCASR President Umesh Waghmare said the partnership represents a landmark step for the institution, bringing together complementary capabilities in genetics, molecular and chemical biology, and computational biology. He added that the collaboration would open new pathways to deliver societal impact while contributing to national scientific and innovation missions.

A new Letter of Intent has been signed to establish a Centre of Excellence for CRISPR Innovation and Translation, aimed at harnessing advanced CRISPR technologies to convert laboratory research into real-world clinical applications. The proposed centre will act as a dedicated hub to accelerate the translation of scientific discoveries into affordable and scalable healthcare solutions. The Jawaharlal Nehru Centre for Advanced Scientific Research, Bengaluru—an autonomous institute under the Department of Science and Technology—and Delhi-based CrisprBits Private Limited have jointly announced the initiative, marking one of India’s early public–private partnerships in CRISPR-based biotechnology. CrisprBits specialises in gene-editing platforms focused on developing cost-effective diagnostic and therapeutic solutions. The Centre of Excellence is envisioned as a bridge between fundamental research and clinical impact, combining JNCASR’s strengths in biomedical sciences with CrisprBits’ expertise in applied gene-editing and translational technologies. By addressing the long-standing gap between laboratory innovation and bedside application, the centre aims to demonstrate how Indian scientific research can be effectively transformed into societal and clinical benefits. It is also expected to serve as a replicable national model for strengthening collaboration between academia and industry within India’s biotechnology ecosystem. Commenting on the development, JNCASR President Umesh Waghmare said the partnership represents a landmark step for the institution, bringing together complementary capabilities in genetics, molecular and chemical biology, and computational biology. He added that the collaboration would open new pathways to deliver societal impact while contributing to national scientific and innovation missions.

Related Stories

Gold Stories

Next Story
Equipment

BEML Wins GeM Award for Highest MSE Order Value

BEML Limited has received the “Maximum Order Value to MSEs” award at the 10th Foundation Day celebrations of the Government e-Marketplace (GeM) held at Bharat Mandapam, New Delhi.Union Minister of Commerce and Industry Piyush Goyal presented the award, which was received on behalf of BEML by Anil Jerath, Director (Finance).The recognition acknowledges BEML's efforts to strengthen procurement from Micro and Small Enterprises (MSEs) through the GeM platform.BEML said its procurement initiatives are aimed at encouraging greater participation of MSEs in public procurement and supporting the gr..

Next Story
Equipment

BKT to Showcase Advanced Off-Highway Tyres at Bauma ConExpo

Balkrishna Industries Ltd (BKT) will showcase its latest off-highway tyre solutions at Bauma ConExpo India 2026, scheduled from September 15-18 at the India Expo Centre, Greater Noida.The company will display a range of application-specific tyres for construction, mining and industrial operations at Hall 12, Booth No. 1. Key products will include the EARTHMAX SR 30 for loaders and articulated dump trucks and the AIROMAX AM 27 for mobile cranes.BKT will also showcase MINE FORCE, EARTHMAX EXPERTO GD1, XL GRIP NEO, DYNA HAUL, CONSTEER and EARTHMAX SR423. The tyres are designed to operate under he..

Next Story
Products

Koemmerling opens Navi Mumbai experience centre

Koemmerling, a brand of the profine Group, has expanded its presence in the Mumbai metropolitan region with the opening of a new experience centre in Navi Mumbai and launched its Allure S46 minimal sliding door system for the Indian market.Located in CBD Belapur, the facility was inaugurated by Peter Mrosik, Owner and CEO, profine Group, along with Farid Khan, Chairman and Managing Director, profine India, and Kamal Bajaj, CEO, profine India.The company said the new centre will showcase its portfolio of uPVC and aluminium window and door systems to architects, developers and homeowners.The ina..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement